Urinary exosomal AR-V7 as a predictive biomarker for treatment outcomes in castration-resistant prostate cancer
Canadian Journal of Urology · Jingcheng Lyu, Ruiyu Yue, Yukun Liu et al. · 2026
- EnglishRead in your language
- CitedEvery fact sourced
- Ad-freeNo ads, no tracking
Quick facts
Questions
- Who wrote Urinary exosomal AR-V7 as a predictive biomarker for treatment outcomes in castration-resistant prostate cancer?
- Urinary exosomal AR-V7 as a predictive biomarker for treatment outcomes in castration-resistant prostate cancer was written by Jingcheng Lyu, Ruiyu Yue, Yukun Liu, Bo Song.
- When was Urinary exosomal AR-V7 as a predictive biomarker for treatment outcomes in castration-resistant prostate cancer first published?
- Urinary exosomal AR-V7 as a predictive biomarker for treatment outcomes in castration-resistant prostate cancer was first published in 2026.
Sources
Last updated · facts checked 2 November 2026
Cite this page
"Urinary exosomal AR-V7 as a predictive biomarker for treatment outcomes in castration-resistant prostate cancer". DigiNepal. Last updated 2 October 2026. https://diginpl.com/books/paper-cju-2026-084989. Retrieved 14 November 2026.
Open-access publication. Read it free at the publisher: https://doi.org/10.32604/cju.2026.084989.